BEAM
Beam Therapeutics Inc. · Healthcare · Market cap $2.5B
Insiders sold $1.6M net in the last 90 days ·3 sellers, 0 buyers· 4 of 4 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 17, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$19.7M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Latest filing
Oct 17, 2026
Evans John M.
Beam Therapeutics Inc. (BEAM) has 29 SEC Form 4 filings (53 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Oct 17, 2026.
Inside the rolling window, 7 insiders at Beam Therapeutics Inc. reported no open-market purchases and 26 open-market sales totaling $19.7M. The most active filer is CEO Evans John M. with 9 filings. Insiders have net sold $13.4M over the trailing 6 months. The most recent open-market filing is a sale of 25,000 shares by CEO Evans John M., dated Oct 15, 2026, worth $589K.
- Industry:Biotechnology
- CEO:John Evans
- Employees:540
- HQ:Cambridge, MA, US
- IPO:2020-02-06
| Source | |||||||
|---|---|---|---|---|---|---|---|
Evans John M.First in 4 months | CEO | Sale | 25,000 | $589K | Oct 17 | -0.6% | SEC ↗ |
Evans John M.First in 4 months | CEO | Sale | 25,000 | $600K | Oct 17 | -0.6% | SEC ↗ |
Cavanagh Bethany JFirst in 6 months | SVP, Finance and Treasurer | Sale | 187 | $5K | Oct 2 | -1.8% | SEC ↗ |
| Chief Medical Officer | Sale | 16,667 | $429K | Jul 29 | -7.6% | SEC ↗ | |
| Chief Medical Officer | Sale | 373 | $13K | Jul 2 | -30.9% | SEC ↗ | |
| CEO | Sale | 25,000 | $887K | Jul 1 | -28.2% | SEC ↗ | |
| CEO | Sale | 25,000 | $858K | Jul 1 | -28.2% | SEC ↗ | |
FMR LLCFirst in 8 months | See Remark 1 | Sale | 33,372 | $1.2M | Jun 29 | -31.2% | SEC ↗ |
FMR LLCFirst in 8 months | See Remark 1 | Sale | 251,488 | $8.9M | Jun 29 | — | SEC ↗ |
Simon AmyFirst filing | Chief Medical Officer | Sale | 6,700 | $165K | Apr 6 | — | SEC ↗ |
| President | Sale | 11,810 | $290K | Apr 6 | — | SEC ↗ | |
| Chief Legal Officer | Sale | 5,956 | $146K | Apr 6 | — | SEC ↗ | |
| CEO | Sale | 30,078 | $739K | Apr 6 | — | SEC ↗ | |
| SVP, Finance and Treasurer | Sale | 3,242 | $80K | Apr 6 | — | SEC ↗ | |
| CEO | Sale | 25,000 | $559K | Apr 1 | — | SEC ↗ | |
| CEO | Sale | 25,000 | $569K | Apr 1 | — | SEC ↗ | |
Ciaramella GiuseppeFirst filing | President | Sale | 35,000 | $1.1M | Feb 26 | — | SEC ↗ |
Evans John M.First filing | CEO | Sale | 25,000 | $735K | Feb 2 | — | SEC ↗ |
Evans John M.First filing | CEO | Sale | 25,000 | $709K | Feb 2 | — | SEC ↗ |
| Chief Legal Officer | Sale | 1,371 | $47K | Jan 26 | — | SEC ↗ | |
| SVP, Finance and Treasurer | Sale | 6,198 | $217K | Jan 26 | — | SEC ↗ | |
Cavanagh Bethany JFirst filing | SVP, Finance and Treasurer | Sale | 3,034 | $91K | Jan 21 | — | SEC ↗ |
| Chief Legal Officer | Sale | 18,629 | $645K | Jan 20 | — | SEC ↗ | |
Emany Sravan KumarFirst filing | Chief Financial Officer | Sale | 6,294 | $171K | Jan 5 | — | SEC ↗ |
Bellon ChristineFirst filing | Chief Legal Officer | Sale | 1,254 | $34K | Jan 5 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does BEAM have?
Beam Therapeutics Inc. (BEAM) has 29 SEC Form 4 filings (53 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: Oct 17, 2026.
When was the most recent SEC Form 4 filing for BEAM?
The most recent Form 4 filing for BEAM on Tracefour is dated Oct 17, 2026.
Who is the most active insider at BEAM?
The most active SEC Form 4 filer at BEAM in the rolling window is CEO Evans John M., with 9 filings.
What is the net insider flow at BEAM over the last 6 months?
Over the trailing 180 days, insiders at BEAM have net sold $13.4M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at BEAM in the current window?
Inside the rolling window, insiders at BEAM bought $0 and sold $19.7M based on SEC Form 4 filings.
Can I get alerts for BEAM insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Beam Therapeutics Inc. (BEAM). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Beam Therapeutics Inc. is in the Healthcare sector.